EquityZen Growth Technology Fund LLC - Series 47
Raised
$231K
Investors
12
Min Invest
$0
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 47 is a Delaware pooled investment fund that raised $231K from 12 investors under Rule 506(b) and Section 3(c)(1). This amended filing is part of the EquityZen platform, which sponsors pre-IPO investment vehicles enabling access to private company equity. The filing shows standard platform structure with Shriram Bhashyam and Inc. Equity Zen as executive officers/directors.
This pre-IPO fund vehicle uses the 506(b) private placement exemption combined with 3(c)(1) Investment Company Act relief, a standard pattern for pooled funds limiting investors to 99 qualified purchasers. The $19K average investor commitment reflects EquityZen's model of fractionalizing access to private growth-stage companies, typical for retail-accessible pre-IPO platforms.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Equity Zen Inc.
Executive Officer, Director · New York, NY
Shriram Bhashyam
Executive Officer, Director · New York, NY
Assure Fund Management II LLC
Director · Salt Lake City, UT
Jens Beyrich
Executive Officer · Salt Lake City, UT
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
